Igarashi; Rie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Igarashi; Rie.The latest application filed is for "transdermal absorption enhancer".

Company Profile

0.9.12

Igarashi; Rie - Kanagawa JP
Igarashi; Rie - Nara-shi JP
Igarashi; Rie - Kawasaki JP
Igarashi, Rie - Kawasaki-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane Grant 9,095,560 - Yamaguchi , et al. August 4, 2	2015-08-04
Transdermal Absorption Enhancer App 20110081418 - Yamaguchi; Yoko ; et al.	2011-04-07
Therapeutic Agent For Local Inflammation App 20110081410 - Igarashi; Rie	2011-04-07
Dermal Regeneration Enhancer App 20100305215 - YAMAGUCHI; Yoko ; et al.	2010-12-02
Transdermal Absorption Enhancer App 20090075860 - Yamaguchi; Yoko ; et al.	2009-03-19
Dermal Regeneration Enhancer App 20090017123 - Yamaguchi; Yoko ; et al.	2009-01-15
Retinoic Acid-Containing Antidiabetic Agent App 20080274193 - Yamaguchi; Yoko ; et al.	2008-11-06
Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metal App 20070258926 - Yamaguchi; Yoko ; et al.	2007-11-08
Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle App 20070077286 - Ishihara; Tsutomu ; et al.	2007-04-05
Method of controlling paticle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method App 20070014863 - Yamaguchi; Yoko ; et al.	2007-01-18
Modified BDNF Grant 6,800,607 - Igarashi , et al. October 5, 2	2004-10-05
Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein App 20040185113 - Mizushima, Yutaka ; et al.	2004-09-23
Modified bdnf App 20030073631 - Igarashi, Rie ; et al.	2003-04-17
Sustained release drug compositions App 20020019336 - Kitagawa, Aki ; et al.	2002-02-14
Pharmaceutical preparations for intranasal administration Grant 5,948,749 - Igarashi , et al. September 7, 1	1999-09-07
Medicaments for nasal administration Grant 5,942,242 - Mizushima , et al. August 24, 1	1999-08-24
Sugar modified interferon Grant 5,723,121 - Takenaga , et al. March 3, 1	1998-03-03
Topical preparations containing cyclosporin Grant 5,504,068 - Komiya , et al. April 2, 1	1996-04-02
11-beta, 17-alpha, 21-trihydroxy-1, 4-pregnadiene-3, 20 21-[(E-E)-3,7, 11-trimethyl-2,6,10-dodecatrienoate] Grant 5,278,156 - Mizushima , et al. January 11, 1	1994-01-11
11.beta., 17.alpha.,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] Grant 5,015,746 - Mizushima , et al. May 14, 1	1991-05-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.